Abbott Laboratories
Stock Forecast, Prediction & Price Target
Abbott Laboratories Financial Estimates
Abbott Laboratories Revenue Estimates
Abbott Laboratories EBITDA Estimates
Abbott Laboratories Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $43.07B N/A | $43.65B 1.34% | $40.10B -8.11% | Avg: $44.72B Low: $44.52B High: $44.90B avg. 11.51% | Avg: $47.97B Low: $47.68B High: $48.29B avg. 7.26% | Avg: $51.41B Low: $51.09B High: $51.74B avg. 7.15% | Avg: $54.82B Low: $54.48B High: $55.18B avg. 6.63% |
Net Income
% change YoY
| $7.07B N/A | $6.93B -1.95% | $5.72B -17.45% | Avg: $7.18B Low: $6.19B High: $7.63B avg. 25.55% | Avg: $7.96B Low: $7.27B High: $8.85B avg. 10.81% | Avg: $10.78B Low: $10.69B High: $10.87B avg. 35.44% | Avg: $11.83B Low: $11.73B High: $11.93B avg. 9.70% |
EBITDA
% change YoY
| $10.74B N/A | $10.69B -0.49% | $10.60B -0.85% | Avg: $10.61B Low: $10.56B High: $10.65B avg. 0.08% | Avg: $11.38B Low: $11.31B High: $11.46B avg. 7.26% | Avg: $12.20B Low: $12.12B High: $12.28B avg. 7.15% | Avg: $13.01B Low: $12.92B High: $13.09B avg. 6.63% |
EPS
% change YoY
| $3.97 N/A | $3.94 -0.75% | $3.3 -16.24% | Avg: $4.01 Low: $3.54 High: $4.37 avg. 21.66% | Avg: $4.61 Low: $4.16 High: $5.06 avg. 14.86% | Avg: $6.17 Low: $6.12 High: $6.22 avg. 33.71% | Avg: $6.77 Low: $6.71 High: $6.82 avg. 9.70% |
Operating Expenses
% change YoY
| $16.11B N/A | $16.14B 0.22% | $15.65B -3.05% | Avg: $12.34B Low: $12.28B High: $12.39B avg. -21.16% | Avg: $13.24B Low: $13.15B High: $13.32B avg. 7.26% | Avg: $14.18B Low: $14.09B High: $14.28B avg. 7.15% | Avg: $15.12B Low: $15.03B High: $15.22B avg. 6.63% |
FAQ
What is Abbott Laboratories stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 20.38% in 2025-2028.
We have gathered data from 14 analysts. Their low estimate is 6.19B, average is 7.18B and high is 7.63B.
What is Abbott Laboratories stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 8.14% in 2025-2028.
We have gathered data from 18 analysts. Their low revenue estimate is $44.52B, average is $44.72B and high is $44.90B.
What is Abbott Laboratories stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 19.98% in 2025-2028.
We have gathered data from 14 analysts. Their low earnings per share estimate is $3.54, average is $4.01 and high is $4.36.
What is the best performing analyst?
In the last twelve months analysts have been covering Abbott Laboratories stock. The most successful analyst is Adam Maeder.